Linked Data API

Show Search Form

Search Results

982463
registered interest false more like this
date less than 2018-10-08more like thismore than 2018-10-08
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Pharmaceutical Price Regulation Scheme more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the next Pharmaceutical Price Regulation Scheme considers combination treatments for cancer to be cost-effective. more like this
tabling member constituency Carshalton and Wallington remove filter
tabling member printed
Tom Brake more like this
uin 175794 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-10-16more like thismore than 2018-10-16
answer text <p>The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective, innovative cancer treatments and technologies at a price the National Health Service can afford. Discussions on a branded medicines voluntary agreement for 2019 onwards are ongoing and are constructive.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine remove filter
grouped question UIN 175795 remove filter
question first answered
less than 2018-10-16T11:01:56.86Zmore like thismore than 2018-10-16T11:01:56.86Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
151
label Biography information for Tom Brake more like this